Parkinsons disease Drug Market Report

China Parkinsons disease Drug Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 22, 2022
  • PAGES：154
  • REPORT CODE：GMM1102605
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Parkinsons disease Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Parkinsons disease Drug market. Detailed analysis of key players, along with key growth strategies adopted by Parkinsons disease Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Valeant Pharmaceuticals

    • Merck

    • Sun Pharma

    • Wockhardt

    • UCB

    • Impax Laboratories

    • AbbVie

    • GSK

    • Boehringer Ingelheim

    • Teva

    • Acadia

    • Novartis AG

    • Lundbeck

    By Type:

    • Carbidopa/Levodopa

    • Dopamine Receptor Agonists

    • MAO-Inhibitors

    By End-User:

    • Hospital

    • Online

    • Retail Pharmacies

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Parkinsons disease Drug Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Parkinsons disease Drug Market Size and Growth Rate of Carbidopa/Levodopa from 2016 to 2027

    • 1.3.2 China Parkinsons disease Drug Market Size and Growth Rate of Dopamine Receptor Agonists from 2016 to 2027

    • 1.3.3 China Parkinsons disease Drug Market Size and Growth Rate of MAO-Inhibitors from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Parkinsons disease Drug Market Size and Growth Rate of Hospital from 2016 to 2027

    • 1.4.2 China Parkinsons disease Drug Market Size and Growth Rate of Online from 2016 to 2027

    • 1.4.3 China Parkinsons disease Drug Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Parkinsons disease Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Parkinsons disease Drug by Major Types

    • 3.4.1 Market Size and Growth Rate of Carbidopa/Levodopa

    • 3.4.2 Market Size and Growth Rate of Dopamine Receptor Agonists

    • 3.4.3 Market Size and Growth Rate of MAO-Inhibitors

    4 Segmentation of Parkinsons disease Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Parkinsons disease Drug by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Parkinsons disease Drug in Hospital

    • 4.4.2 Market Size and Growth Rate of Parkinsons disease Drug in Online

    • 4.4.3 Market Size and Growth Rate of Parkinsons disease Drug in Retail Pharmacies

    5 Market Analysis by Regions

    • 5.1 China Parkinsons disease Drug Production Analysis by Regions

    • 5.2 China Parkinsons disease Drug Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Parkinsons disease Drug Landscape Analysis

    • 6.1 North China Parkinsons disease Drug Landscape Analysis by Major Types

    • 6.2 North China Parkinsons disease Drug Landscape Analysis by Major End-Users

    7 Central China Parkinsons disease Drug Landscape Analysis

    • 7.1 Central China Parkinsons disease Drug Landscape Analysis by Major Types

    • 7.2 Central China Parkinsons disease Drug Landscape Analysis by Major End-Users

    8 South China Parkinsons disease Drug Landscape Analysis

    • 8.1 South China Parkinsons disease Drug Landscape Analysis by Major Types

    • 8.2 South China Parkinsons disease Drug Landscape Analysis by Major End-Users

    9 East China Parkinsons disease Drug Landscape Analysis

    • 9.1 East China Parkinsons disease Drug Landscape Analysis by Major Types

    • 9.2 East China Parkinsons disease Drug Landscape Analysis by Major End-Users

    10 Northeast China Parkinsons disease Drug Landscape Analysis

    • 10.1 Northeast China Parkinsons disease Drug Landscape Analysis by Major Types

    • 10.2 Northeast China Parkinsons disease Drug Landscape Analysis by Major End-Users

    11 Southwest China Parkinsons disease Drug Landscape Analysis

    • 11.1 Southwest China Parkinsons disease Drug Landscape Analysis by Major Types

    • 11.2 Southwest China Parkinsons disease Drug Landscape Analysis by Major End-Users

    12 Northwest China Parkinsons disease Drug Landscape Analysis

    • 12.1 Northwest China Parkinsons disease Drug Landscape Analysis by Major Types

    • 12.2 Northwest China Parkinsons disease Drug Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Valeant Pharmaceuticals

      • 13.1.1 Valeant Pharmaceuticals Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Merck

      • 13.2.1 Merck Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Sun Pharma

      • 13.3.1 Sun Pharma Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Wockhardt

      • 13.4.1 Wockhardt Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 UCB

      • 13.5.1 UCB Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Impax Laboratories

      • 13.6.1 Impax Laboratories Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 AbbVie

      • 13.7.1 AbbVie Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 GSK

      • 13.8.1 GSK Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Boehringer Ingelheim

      • 13.9.1 Boehringer Ingelheim Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Teva

      • 13.10.1 Teva Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    • 13.11 Acadia

      • 13.11.1 Acadia Company Profile and Recent Development

      • 13.11.2 Market Performance

      • 13.11.3 Product and Service Introduction

    • 13.12 Novartis AG

      • 13.12.1 Novartis AG Company Profile and Recent Development

      • 13.12.2 Market Performance

      • 13.12.3 Product and Service Introduction

    • 13.13 Lundbeck

      • 13.13.1 Lundbeck Company Profile and Recent Development

      • 13.13.2 Market Performance

      • 13.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Parkinsons disease Drug Market Size and Growth Rate of Carbidopa/Levodopa from 2016 to 2027

    • Figure China Parkinsons disease Drug Market Size and Growth Rate of Dopamine Receptor Agonists from 2016 to 2027

    • Figure China Parkinsons disease Drug Market Size and Growth Rate of MAO-Inhibitors from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Parkinsons disease Drug Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure China Parkinsons disease Drug Market Size and Growth Rate of Online from 2016 to 2027

    • Figure China Parkinsons disease Drug Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Parkinsons disease Drug Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Parkinsons disease Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Parkinsons disease Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Parkinsons disease Drug by Different Types from 2016 to 2027

    • Table Consumption Share of Parkinsons disease Drug by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Carbidopa/Levodopa

    • Figure Market Size and Growth Rate of Dopamine Receptor Agonists

    • Figure Market Size and Growth Rate of MAO-Inhibitors

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Parkinsons disease Drug by Different End-Users from 2016 to 2027

    • Table Consumption Share of Parkinsons disease Drug by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Online

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Table China Parkinsons disease Drug Production by Regions

    • Table China Parkinsons disease Drug Production Share by Regions

    • Figure China Parkinsons disease Drug Production Share by Regions in 2016

    • Figure China Parkinsons disease Drug Production Share by Regions in 2021

    • Figure China Parkinsons disease Drug Production Share by Regions in 2027

    • Table China Parkinsons disease Drug Consumption by Regions

    • Table China Parkinsons disease Drug Consumption Share by Regions

    • Figure China Parkinsons disease Drug Consumption Share by Regions in 2016

    • Figure China Parkinsons disease Drug Consumption Share by Regions in 2021

    • Figure China Parkinsons disease Drug Consumption Share by Regions in 2027

    • Table North China Parkinsons disease Drug Consumption by Types from 2016 to 2027

    • Table North China Parkinsons disease Drug Consumption Share by Types from 2016 to 2027

    • Figure North China Parkinsons disease Drug Consumption Share by Types in 2016

    • Figure North China Parkinsons disease Drug Consumption Share by Types in 2021

    • Figure North China Parkinsons disease Drug Consumption Share by Types in 2027

    • Table North China Parkinsons disease Drug Consumption by End-Users from 2016 to 2027

    • Table North China Parkinsons disease Drug Consumption Share by End-Users from 2016 to 2027

    • Figure North China Parkinsons disease Drug Consumption Share by End-Users in 2016

    • Figure North China Parkinsons disease Drug Consumption Share by End-Users in 2021

    • Figure North China Parkinsons disease Drug Consumption Share by End-Users in 2027

    • Table Central China Parkinsons disease Drug Consumption by Types from 2016 to 2027

    • Table Central China Parkinsons disease Drug Consumption Share by Types from 2016 to 2027

    • Figure Central China Parkinsons disease Drug Consumption Share by Types in 2016

    • Figure Central China Parkinsons disease Drug Consumption Share by Types in 2021

    • Figure Central China Parkinsons disease Drug Consumption Share by Types in 2027

    • Table Central China Parkinsons disease Drug Consumption by End-Users from 2016 to 2027

    • Table Central China Parkinsons disease Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Parkinsons disease Drug Consumption Share by End-Users in 2016

    • Figure Central China Parkinsons disease Drug Consumption Share by End-Users in 2021

    • Figure Central China Parkinsons disease Drug Consumption Share by End-Users in 2027

    • Table South China Parkinsons disease Drug Consumption by Types from 2016 to 2027

    • Table South China Parkinsons disease Drug Consumption Share by Types from 2016 to 2027

    • Figure South China Parkinsons disease Drug Consumption Share by Types in 2016

    • Figure South China Parkinsons disease Drug Consumption Share by Types in 2021

    • Figure South China Parkinsons disease Drug Consumption Share by Types in 2027

    • Table South China Parkinsons disease Drug Consumption by End-Users from 2016 to 2027

    • Table South China Parkinsons disease Drug Consumption Share by End-Users from 2016 to 2027

    • Figure South China Parkinsons disease Drug Consumption Share by End-Users in 2016

    • Figure South China Parkinsons disease Drug Consumption Share by End-Users in 2021

    • Figure South China Parkinsons disease Drug Consumption Share by End-Users in 2027

    • Table East China Parkinsons disease Drug Consumption by Types from 2016 to 2027

    • Table East China Parkinsons disease Drug Consumption Share by Types from 2016 to 2027

    • Figure East China Parkinsons disease Drug Consumption Share by Types in 2016

    • Figure East China Parkinsons disease Drug Consumption Share by Types in 2021

    • Figure East China Parkinsons disease Drug Consumption Share by Types in 2027

    • Table East China Parkinsons disease Drug Consumption by End-Users from 2016 to 2027

    • Table East China Parkinsons disease Drug Consumption Share by End-Users from 2016 to 2027

    • Figure East China Parkinsons disease Drug Consumption Share by End-Users in 2016

    • Figure East China Parkinsons disease Drug Consumption Share by End-Users in 2021

    • Figure East China Parkinsons disease Drug Consumption Share by End-Users in 2027

    • Table Northeast China Parkinsons disease Drug Consumption by Types from 2016 to 2027

    • Table Northeast China Parkinsons disease Drug Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Parkinsons disease Drug Consumption Share by Types in 2016

    • Figure Northeast China Parkinsons disease Drug Consumption Share by Types in 2021

    • Figure Northeast China Parkinsons disease Drug Consumption Share by Types in 2027

    • Table Northeast China Parkinsons disease Drug Consumption by End-Users from 2016 to 2027

    • Table Northeast China Parkinsons disease Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Parkinsons disease Drug Consumption Share by End-Users in 2016

    • Figure Northeast China Parkinsons disease Drug Consumption Share by End-Users in 2021

    • Figure Northeast China Parkinsons disease Drug Consumption Share by End-Users in 2027

    • Table Southwest China Parkinsons disease Drug Consumption by Types from 2016 to 2027

    • Table Southwest China Parkinsons disease Drug Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Parkinsons disease Drug Consumption Share by Types in 2016

    • Figure Southwest China Parkinsons disease Drug Consumption Share by Types in 2021

    • Figure Southwest China Parkinsons disease Drug Consumption Share by Types in 2027

    • Table Southwest China Parkinsons disease Drug Consumption by End-Users from 2016 to 2027

    • Table Southwest China Parkinsons disease Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Parkinsons disease Drug Consumption Share by End-Users in 2016

    • Figure Southwest China Parkinsons disease Drug Consumption Share by End-Users in 2021

    • Figure Southwest China Parkinsons disease Drug Consumption Share by End-Users in 2027

    • Table Northwest China Parkinsons disease Drug Consumption by Types from 2016 to 2027

    • Table Northwest China Parkinsons disease Drug Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Parkinsons disease Drug Consumption Share by Types in 2016

    • Figure Northwest China Parkinsons disease Drug Consumption Share by Types in 2021

    • Figure Northwest China Parkinsons disease Drug Consumption Share by Types in 2027

    • Table Northwest China Parkinsons disease Drug Consumption by End-Users from 2016 to 2027

    • Table Northwest China Parkinsons disease Drug Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Parkinsons disease Drug Consumption Share by End-Users in 2016

    • Figure Northwest China Parkinsons disease Drug Consumption Share by End-Users in 2021

    • Figure Northwest China Parkinsons disease Drug Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Valeant Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals

    • Table Product and Service Introduction of Valeant Pharmaceuticals

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of Sun Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharma

    • Figure Sales and Growth Rate Analysis of Sun Pharma

    • Figure Revenue and Market Share Analysis of Sun Pharma

    • Table Product and Service Introduction of Sun Pharma

    • Table Company Profile and Development Status of Wockhardt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Wockhardt

    • Figure Sales and Growth Rate Analysis of Wockhardt

    • Figure Revenue and Market Share Analysis of Wockhardt

    • Table Product and Service Introduction of Wockhardt

    • Table Company Profile and Development Status of UCB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB

    • Figure Sales and Growth Rate Analysis of UCB

    • Figure Revenue and Market Share Analysis of UCB

    • Table Product and Service Introduction of UCB

    • Table Company Profile and Development Status of Impax Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Impax Laboratories

    • Figure Sales and Growth Rate Analysis of Impax Laboratories

    • Figure Revenue and Market Share Analysis of Impax Laboratories

    • Table Product and Service Introduction of Impax Laboratories

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of Boehringer Ingelheim

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim

    • Table Product and Service Introduction of Boehringer Ingelheim

    • Table Company Profile and Development Status of Teva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva

    • Figure Sales and Growth Rate Analysis of Teva

    • Figure Revenue and Market Share Analysis of Teva

    • Table Product and Service Introduction of Teva

    • Table Company Profile and Development Status of Acadia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acadia

    • Figure Sales and Growth Rate Analysis of Acadia

    • Figure Revenue and Market Share Analysis of Acadia

    • Table Product and Service Introduction of Acadia

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Lundbeck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lundbeck

    • Figure Sales and Growth Rate Analysis of Lundbeck

    • Figure Revenue and Market Share Analysis of Lundbeck

    • Table Product and Service Introduction of Lundbeck


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US